ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 85 filers reported holding ALLOVIR INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,184 | -36.8% | 6,597,167 | 0.0% | 0.61% | -12.5% |
| Q2 2023 | $22,430 | +2.1% | 6,597,167 | +18.3% | 0.70% | -46.8% |
| Q1 2023 | $21,974 | -23.2% | 5,577,167 | 0.0% | 1.31% | -18.2% |
| Q4 2022 | $28,611 | -99.9% | 5,577,167 | 0.0% | 1.60% | -15.0% |
| Q3 2022 | $44,004,000 | +385.6% | 5,577,167 | +140.0% | 1.88% | +288.0% |
| Q2 2022 | $9,061,000 | -42.2% | 2,323,371 | 0.0% | 0.48% | -26.3% |
| Q1 2022 | $15,683,000 | -47.8% | 2,323,371 | 0.0% | 0.66% | -19.5% |
| Q4 2021 | $30,064,000 | -48.4% | 2,323,371 | 0.0% | 0.82% | -37.4% |
| Q3 2021 | $58,224,000 | +27.0% | 2,323,371 | 0.0% | 1.30% | +40.0% |
| Q2 2021 | $45,863,000 | -15.6% | 2,323,371 | 0.0% | 0.93% | -3.1% |
| Q1 2021 | $54,367,000 | -39.1% | 2,323,371 | 0.0% | 0.96% | -49.9% |
| Q4 2020 | $89,310,000 | +39.8% | 2,323,371 | 0.0% | 1.92% | +23.6% |
| Q3 2020 | $63,893,000 | – | 2,323,371 | – | 1.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |